Skip to main content
. Author manuscript; available in PMC: 2023 Mar 17.
Published in final edited form as: J Alzheimers Dis. 2017;56(1):335–349. doi: 10.3233/JAD-160916

Fig. 4.

Fig. 4.

TFP5 administration reduces neuroinflammation. A) Western blots of brain lysates prepared from non-p25 expressing (lanes 1, 2) and p25-expressing animals (lanes 3, 4) treated with TFP5 according to the standard protocol. Antibodies to inflammatory cytokines in astrocytes and microglia show a significant reduction in inflammatory response as a result of the TFP5 injection protocol. B) Density scans of the blots with Image J software show a significant reduction of inflammatory response after TFP5 administration. (n = 5; p < 0.05).